The number of people with susceptibility test result for rifampicin in Uzbekistan
Uzbekistan: The number of people with susceptibility test result for rifampicin was 4,929 in 2021. ▬ Flat
Latest (2021)
4,929
Change on year
up 24.9%
World rank
29th
of 155 countries
All-time high
5,249
in 2019
All-time low
3,946
in 2020
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Uzbekistan, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
In 2021, the number of people with susceptibility test result for rifampicin in Uzbekistan stood at 4,929.
Compared with earlier readings it is up 24.9% on the previous year and up 11.0% over five years.
Uzbekistan ranks 29th of 155 countries on this measure, in the top quarter.
The number of people with susceptibility test result for rifampicin in Uzbekistan, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 4,439 | — |
| 2018 | 4,828 | +8.8% |
| 2019 | 5,249 | +8.7% |
| 2020 | 3,946 | -24.8% |
| 2021 | 4,929 | +24.9% |
Uzbekistan compared with similar countries
- Uzbekistan's 4,929 is above the median for lower middle income countries, which is 2,804, 1.8× the median. (32 countries reporting)
- Uzbekistan's 4,929 is above the median for Europe & Central Asia, which is 229.5, 21.5× the median. (44 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 4,839 | 4,439 | 5,249 | 3 |
| 2020s | 4,438 | 3,946 | 4,929 | 2 |
Countries ranked near Uzbekistan
More health data for Uzbekistan
- Un projection of annual infant deaths, annual growth rate -1.21 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.2049 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 782.5 deaths per 1,000 people (2090)
- Number of infants who die before age 1 3,269 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2024)
- Population ages 00-04, female, annual growth rate 1.88 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0589 units per person (2025)
- Population ages 00-04, male, annual growth rate 1.77 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Uzbekistan?
- The number of people with susceptibility test result for rifampicin in Uzbekistan was 4,929 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Uzbekistan?
- The highest recorded value was 5,249 in 2019.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Uzbekistan?
- The lowest recorded value was 3,946 in 2020.
- How does Uzbekistan rank for the number of people with susceptibility test result for rifampicin?
- Uzbekistan ranks 29th out of 155 countries with data for 2021.
- Where does this Uzbekistan data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).